FORM 38.5(B) REPORT OSMOTICA BCI

LONDON--()-- 

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

Name of exempt principal trader: BARCLAYS CAPITAL INC
Company dealt in OSMOTICA PHARMACEUTICALS PLC
Class of relevant security to which the US$0.01 ordinary shares
dealings being disclosed relate
Date of dealing 29 March 2021

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Class of relevant security: ORD

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

320

0.00%

0

0.00%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

0

0.00%

0

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

(4)

 

 

 

 

TOTAL:

320

0.00%

0

0.00%

 

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap28

3. DEALINGS (Note 3)

a. Purchases and sales

Purchase/sale Number of Price per unit
securities
Purchase

100

3.6300 USD

Purchase

100

3.7000 USD

Purchase

100

3.9700 USD

Purchase

100

3.9250 USD

Purchase

200

3.8525 USD

Purchase

400

3.8450 USD

Purchase

1,200

3.8675 USD

Sale

2,200

3.8509 USD

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

 

 

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

d. Other dealings (including transactions in respect of new securities) (Note 3)

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 38.5(b) attached? NO
Date of disclosure: 30 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

Name of offeree/offeror with which connected
Nature of connection

 

 

Category Code: MSCH
Sequence Number: 734170
Time of Receipt (offset from UTC): 20210330T105258+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC